Thursday, 13 June 2024 | 14:30 - 15:15
Pitch session
The following selected pitch presenters will share their innovative project results, technologies, products or services contributing to the development of next generation vaccines and immunotherapy:
-
Presenting LVT-001, a unique mucosal vaccine up to stop viral infection contagiousness – Serge Pampfer, Lovaltech
-
Therapeutic vaccination with auto-antigen mRNA loaded Tol-cLNP cures murine model of multiple sclerosis – Paulien Baeten, Hasselt University & etherna BV
-
XVR013m, a variant-proof antibody with exceptional potency to prevent and treat COVID-19 – Viki Bockstal, ExeVir
-
Innovative Antigen Design: Integrating AI and cryoEM for Next-Generation Vaccines - Moises Maestro, PUXANO
-
Intratumoral administration of autologous myeloid dendritic cells with the immunologic adjuvant AS01B in refractory advanced melanoma: a phase I clinical trial – Manon Vounckx, VUB
-
P95: From Epidemiology Consulting to Comprehensive Vaccine CRO – Kaatje Bollaerts, P95
-
High-sensitive immunopeptidomics uncovers actionable antigens paving the way for optimized vaccine development – Pieter-Paul Strybol, ImmuneSpec
-
New class of cancer vaccine based on an off-the-shelf Antigen Presenting Cell line (PDC*line) – Eric Halioua, PDC*line Pharma
8 speakers